Abstract
Purpose
Unexpected parotid cancers are often encountered due to inaccuracies in the preoperative evaluation. This study aimed to examine the clinical characteristics and oncological outcomes of these cancers and to propose the appropriate management strategy.
Methods
This is a multicenter case series study in which a total of 302 patients were diagnosed postoperatively with parotid cancers between 2003 and 2017. Of these, 85 cases without evidence of malignancy prior to surgery but identified as malignant on postoperative pathology were included.
Results
Of 85 patients, 76 and 9 underwent superficial and total parotidectomy, respectively. A positive resection margin was present in 24.7% of the cases. Postoperative radiotherapy was administered to 43.6% of patients; 4.2% had a local recurrence, and no patients died of the disease. The 5-year overall and relapse-free survival rates were 100.0% and 95.2%, respectively. Patients who underwent piecemeal resection had significantly poorer oncologic outcomes. Age, sex, histologic grade, T stage, extracapsular extension, resection margin status, and postoperative radiotherapy did not affect recurrence and survival.
Conclusion
Preoperatively unexpected parotid cancers had excellent local control and overall survival despite positive or close resection margin, with or without postoperative radiotherapy. Therefore, patients with unexpected parotid malignancies may benefit from less aggressive postoperative management option.
Similar content being viewed by others
Data availability
Not applicable. The data in this study is not deposited.
Code availability
Not applicable.
References
Kane WJ, McCaffrey TV, Olsen KD, Lewis JE (1991) Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117:307–315. https://doi.org/10.1001/archotol.1991.01870150075010
Jeong WJ, Park SJ, Cha W, Sung MW, Kim KH, Ahn SH (2013) Fine needle aspiration of parotid tumors: diagnostic utility from a clinical perspective. J Oral Maxillofac Surg 71:1278–1282. https://doi.org/10.1016/j.joms.2013.01.017
El-Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ (eds) (2017) WHO classification of head and neck tumours, 4th edn. International Agency for Research on Cancer, Lyon
Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) (2017) AJCC cancer staging manual, 8th edn. Springer, New York
Ryu IS, Roh JL, Cho KJ, Lee SW, Choi SH, Nam SY, Kim SY (2013) Clinical outcomes of patients with salivary gland carcinomas preoperatively misdiagnosed as benign lesions. Head Neck 35:1764–1770. https://doi.org/10.1002/hed.23228
Kim BY, Hyeon J, Ryu G, Choi N, Baek CH, Ko YH, Jeong HS (2013) Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors. Ann Surg Oncol 20:2380–2387. https://doi.org/10.1245/s10434-013-2903-z
Gavín-Clavero MA, Usón-Bouthelier T, Jariod-Ferrer UM, Fernández-Larrañaga A, Pantilie B, Lobera-Molina F, Simón-Sanz MV, Nadal Cristóbal B (2018) Accuracy of FNAC and CT in the differentiation of benign and malignant parotid tumours in a case series. Acta Otorrinolaringol Esp 69:25–29. https://doi.org/10.1016/j.otorri.2017.05.003
Schmidt RL, Hunt JP, Hall BJ, Wilson AR, Layfield LJ (2011) A systematic review and meta-analysis of the diagnostic accuracy of frozen section for parotid gland lesions. Am J Clin Pathol 136:729–738. https://doi.org/10.1309/AJCP2SD8RFQEUZJW
Badoual C, Rousseau A, Heudes D, Carnot F, Danel C, Meatchi T, Hans S, Bruneval P, Brasnu D, Laccourreye O (2006) Evaluation of frozen section diagnosis in 721 parotid gland lesions. Histopathology 49:538–540. https://doi.org/10.1111/j.1365-2559.2006.02527.x
Erovic BM, Shah MD, Bruch G, Johnston M, Kim J, O'Sullivan B, Perez-Ordonez B, Weinreb I, Atenafu EG, de Almeida JR, Gullane PJ, Brown D, Gilbert RW, Irish JC, Goldstein DP (2015) Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis. J Otolaryngol Head Neck Surg 44:43. https://doi.org/10.1186/s40463-015-0097-z
Mercante G, Marchese C, Giannarelli D, Pellini R, Cristalli G, Manciocco V, Ruscito P, Pichi B, Marchesi P, Spriano G (2014) Oncological outcome and prognostic factors in malignant parotid tumours. J Craniomaxillofac Surg 42:59–65. https://doi.org/10.1016/j.jcms.2013.02.003
Kandaz M, Soydemir G, Bahat Z, Canyilmaz E, Yoney A (2016) Prognostic factors and clinical outcome in parotid gland tumors: a single institution experience from the Eastern Black Sea region of Turkey. Asian Pac J Cancer Prev 17:1169–1174. https://doi.org/10.7314/apjcp.2016.17.3.1169
Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S (2005) Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133:702–708. https://doi.org/10.1016/j.otohns.2005.08.001
Huyett P, Duvvuri U, Ferris RL, Johnson JT, Schaitkin BM, Kim S (2018) Perineural invasion in parotid gland malignancies. Otolaryngol Head Neck Surg 158:1035–1041. https://doi.org/10.1177/0194599817751888
Hu YH, Zhang CY, Xia RH, Tian Z, Wang LZ, Li J (2016) Prognostic factors of carcinoma ex pleomorphic adenoma of the salivary glands, with emphasis on the widely invasive carcinoma: a clinicopathologic analysis of 361 cases in a Chinese population. Oral Surg Oral Med Oral Pathol Oral Radiol 122:598–608. https://doi.org/10.1016/j.oooo.2016.06.005
Network NCC (2020) Head and neck cancers (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 5 March 2020
Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW (2007) The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys 67:138–143. https://doi.org/10.1016/j.ijrobp.2006.07.1380
Matsuda S, Iguchi H, Tada T, Hosono M, Osawa M, Kuwae Y, Morimoto H, Okazaki E, Amano K, Miki Y, Tsutsumi S, Shimatani Y, Miki Y (2015) Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor. Jpn J Radiol 33:533–537. https://doi.org/10.1007/s11604-015-0450-1
Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ (1997) Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37:79–85. https://doi.org/10.1016/s0360-3016(96)00464-6
Richter SM, Friedmann P, Mourad WF, Hu KS, Persky MS, Harrison LB (2012) Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins. Head Neck 34:953–955. https://doi.org/10.1002/hed.21843
Seethala RR (2009) An update on grading of salivary gland carcinomas. Head Neck Pathol 3:69–77. https://doi.org/10.1007/s12105-009-0102-9
Cho JK, Lim BW, Kim EH, Ko YH, Oh D, Noh JM, Ahn YC, Baek KH, Jeong HS (2016) Low-grade salivary gland cancers: treatment outcomes, extent of surgery and indications for postoperative adjuvant radiation therapy. Ann Surg Oncol 23:4368–4375. https://doi.org/10.1245/s10434-016-5353-6
Stodulski D, Mikaszewski B, Majewska H, Wiśniewski P, Stankiewicz C (2017) Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: outcome of watch and wait policy. Oral Oncol 68:1–4. https://doi.org/10.1016/j.oraloncology.2017.03.001
Acknowledgements
We would like to thank Editage (www.editage.co.kr) for English language editing
Funding
This study was not funded.
Author information
Authors and Affiliations
Contributions
Conceptualization: W-JJ, HP, S-HA; Methodology: W-JJ, HP, YHJ; Formal analysis and investigation: HP, SH, SJP; Writing—original draft preparation: W-JJ, HP; Writing—review and editing: W-JJ, HP, SH, SJP, YHJ; Supervision: W-JJ, S-HA.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (Institutional Review Board) of Seoul National University Bundang Hospital approved this study.
Consent to participate
This study was granted waiver of informed consent to participate from the Human Investigation Committee (Institutional Review Board) of Seoul National University Bungdang Hospital. This permission is based on the following reasons:
1. Obtaining informed consent is not practical in the course of research or has a significant impact on the validity of the research.
2. There is no reason to presume the subject’s refusal to consent, and even if the consent is waived, the risk to the subject is extremely low.
Consent for publication
This study was granted waiver of informed consent from the Human Investigation Committee (Institutional Review Board) of Seoul National University Bundang Hospital. This permission is based on the following reasons:
1. Obtaining informed consent is not practical in the course of research or has a significant impact on the validity of the research.
2. There is no reason to presume the subject’s refusal to consent, and even if the consent is waived, the risk to the subject is extremely low.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Park, H., Han, S., Park, S.J. et al. Oncological outcomes of preoperatively unexpected malignant tumors of the parotid gland. Eur Arch Otorhinolaryngol 278, 2033–2040 (2021). https://doi.org/10.1007/s00405-020-06317-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-06317-9